# FDA Inspection 804715 - Southern California Permanente Medical Group - October 24, 2012

Source: https://www.keypedia.com/records/fda_inspections/southern-california-permanente-medical-group/5b45cd6c-9347-47bd-aa20-18320ba899df
Source feed: FDA_Inspections

> FDA Inspection 804715 for Southern California Permanente Medical Group on October 24, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 804715
- Company Name: Southern California Permanente Medical Group
- Inspection Date: 2012-10-24
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 925038 - 2015-04-03](https://www.keypedia.com/records/fda_inspections/southern-california-permanente-medical-group/72450955-24a7-4243-a2bc-8484ec21eb4f)
- [FDA Inspection 732521 - 2011-06-30](https://www.keypedia.com/records/fda_inspections/southern-california-permanente-medical-group/3efbe20c-42b8-4270-82d9-f789d13c0c59)

Company: https://www.keypedia.com/companies/southern-california-permanente-medical-group/fe50b64e-8c81-4e6f-8d82-caa4e4d7fce0

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d